The present work examined the potential of utilizing ARV-825 and ABBV-744 to increase the effectiveness of tamoxifen or fulvestrant plus palbociclib. ARV-825 was effective in both p53 wild-style (WT) breast tumor cells and in cells missing useful p53 either by itself or in combination with tamoxifen, though the effectiveness of https://jamesm777bny0.salesmanwiki.com/user